Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 747

1.

DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.

Li L, Zheng H, Huang Y, Huang C, Zhang S, Tian J, Li P, Sood AK, Zhang W, Chen K.

Carcinogenesis. 2017 Jun 16. doi: 10.1093/carcin/bgx057. [Epub ahead of print]

PMID:
28637314
2.

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.

Tseng JH, Bisogna M, Hoang LN, Olvera N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Levine DA, Jelinic P.

Sci Rep. 2017 Jun 15;7(1):3614. doi: 10.1038/s41598-017-03972-7.

3.

Role of platelet-derived Tgfβ1 in the progression of ovarian cancer.

Hu Q, Hisamatsu T, Hammerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong ST, Sood AK, Afshar-Kharghan V.

Clin Cancer Res. 2017 Jun 13. pii: clincanres.3272.2016. doi: 10.1158/1078-0432.CCR-16-3272. [Epub ahead of print]

PMID:
28611202
4.

Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatment.

Chung JF, Lee SJ, Sood AK.

Oncotarget. 2017 May 10. doi: 10.18632/oncotarget.17749. [Epub ahead of print] Review.

5.

Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.

Saluja T, Palkar S, Misra P, Gupta M, Venugopal P, Sood AK, Dhati RM, Shetty A, Dhaded SM, Agarkhedkar S, Choudhury A, Kumar R, Balasubramanian S, Babji S, Adhikary L, Dupuy M, Chadha SM, Desai F, Kukian D, Patnaik BN, Dhingra MS.

Vaccine. 2017 Jun 16;35(28):3575-3581. doi: 10.1016/j.vaccine.2017.05.019. Epub 2017 May 20.

PMID:
28536027
6.

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.

Lutgendorf SK, Shinn E, Carter J, Leighton S, Baggerly K, Guindani M, Fellman B, Matzo M, Slavich GM, Goodman MT, Tew W, Lester J, Moore KM, Karlan BY, Levine DA, Sood AK.

Gynecol Oncol. 2017 Jul;146(1):101-108. doi: 10.1016/j.ygyno.2017.05.008. Epub 2017 May 17.

PMID:
28527672
7.

18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.

Vadi SK, Singh B, Basher RK, Watts A, Sood AK, Lal A, Kakkar N, Singh SK.

Clin Nucl Med. 2017 May 19. doi: 10.1097/RLU.0000000000001689. [Epub ahead of print]

PMID:
28525448
8.

Prostate-derived Ets factor, an oncogenic driver in breast cancer.

Sood AK, Geradts J, Young J.

Tumour Biol. 2017 May;39(5):1010428317691688. doi: 10.1177/1010428317691688. Review.

PMID:
28468594
9.

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.

Rabinowicz N, Mangala LS, Brown KR, Checa-Rodriguez C, Castiel A, Moskovich O, Zarfati G, Trakhtenbrot L, Levy-Barda A, Jiang D, Rodriguez-Aguayo C, Pradeep S, van Praag Y, Lopez-Berestein G, David A, Novikov I, Huertas P, Rottapel R, Sood AK, Izraeli S.

Oncotarget. 2017 Apr 18;8(16):27380-27392. doi: 10.18632/oncotarget.16068.

10.

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.

Rashed MH, Kanlikilicer P, Rodriguez-Aguayo C, Pichler M, Bayraktar R, Bayraktar E, Ivan C, Filant J, Silva A, Aslan B, Denizli M, Mitra R, Ozpolat B, Calin GA, Sood AK, Abd-Ellah MF, Helal GK, Berestein GL.

Oncotarget. 2017 Mar 21;8(12):20145-20164. doi: 10.18632/oncotarget.15525.

11.

Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.

Sans M, Gharpure K, Tibshirani R, Zhang J, Liang L, Liu J, Young JH, Dood RL, Sood AK, Eberlin LS.

Cancer Res. 2017 Jun 1;77(11):2903-2913. doi: 10.1158/0008-5472.CAN-16-3044. Epub 2017 Apr 17.

PMID:
28416487
12.

Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.

Wang Y, Xu X, Yu S, Jeong KJ, Zhou Z, Han L, Tsang YH, Li J, Chen H, Mangala LS, Yuan Y, Eterovic AK, Lu Y, Sood AK, Scott KL, Mills GB, Liang H.

Genome Res. 2017 Apr 14. doi: 10.1101/gr.219741.116. [Epub ahead of print]

PMID:
28411194
13.

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.

Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH.

Oncotarget. 2017 Mar 7;8(10):17406. doi: 10.18632/oncotarget.15921. No abstract available.

14.

Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies.

Previs RA, Armaiz-Pena GN, Ivan C, Dalton HJ, Rupaimoole R, Hansen JM, Lyons Y, Huang J, Haemmerle M, Wagner MJ, Gharpure KM, Nagaraja AS, Filant J, McGuire MH, Noh K, Dorniak PL, Linesch SL, Mangala LS, Pradeep S, Wu SY, Sood AK.

J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw296.

PMID:
28376174
15.

Editorial - Metronomic chemotherapy.

Kumar MNVR, Sood AK.

Cancer Lett. 2017 Aug 1;400:203. doi: 10.1016/j.canlet.2017.03.003. Epub 2017 Mar 16. No abstract available.

PMID:
28315702
16.

Featuring the Guest Editors.

Ravi Kumar MNV, Sood AK.

Cancer Lett. 2017 Aug 1;400:204. doi: 10.1016/j.canlet.2017.03.005. Epub 2017 Mar 15. No abstract available.

PMID:
28315431
17.

The Association of Work Characteristics With Ovarian Cancer Risk and Mortality.

Trudel-Fitzgerald C, Poole EM, Idahl A, Lundin E, Sood AK, Kawachi I, Kubzansky LD, Tworoger SS.

Psychosom Med. 2017 Mar 17. doi: 10.1097/PSY.0000000000000464. [Epub ahead of print]

PMID:
28306624
18.

Simple Chemical Treatment to n-Dope Transition-Metal Dichalcogenides and Enhance the Optical and Electrical Characteristics.

Neupane GP, Tran MD, Yun SJ, Kim H, Seo C, Lee J, Han GH, Sood AK, Kim J.

ACS Appl Mater Interfaces. 2017 Apr 5;9(13):11950-11958. doi: 10.1021/acsami.6b15239. Epub 2017 Mar 24.

PMID:
28303716
19.

A clinical study of insulin resistance in patients with chronic pancreatitis.

Kumar KV, Manrai M, Sood AK, Sharma R.

Diabetes Metab Syndr. 2017 Mar 6. pii: S1871-4021(16)30301-0. doi: 10.1016/j.dsx.2017.03.003. [Epub ahead of print]

PMID:
28284910
20.

Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).

Wagner MJ, Mitra R, McArthur MJ, Baze W, Barnhart K, Wu SY, Rodriguez-Aguayo C, Zhang X, Coleman RL, Lopez-Berestein G, Sood AK.

Mol Cancer Ther. 2017 Jun;16(6):1114-1123. doi: 10.1158/1535-7163.MCT-16-0541. Epub 2017 Mar 6.

PMID:
28265009

Supplemental Content

Loading ...
Support Center